Merck's latest earnings call revealed a mix of growth and pain points for the pharmaceutical giant.

Hundreds of thousands of doses of moxidectin – which treats a disease caused by a parasitic worm – are being given to ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

CHATHAM, N.J. - Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a biopharmaceutical company with a market capitalization ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and ...

The search for new tuberculosis drug targets under traditional laboratory methods has historically proven to be arduous and ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

This discovery could also contribute to the development of new drugs for ATTR. "We've unveiled a molecular complexity that has been hidden from researchers for decades, which enables us to design ...

In an effort to safeguard fair market competition and protect consumer interests, the State Council's anti-monopoly ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...